Modulation of tissue factor protein expression in experimental venous bypass grafts

Keith M. Channon, Gregory J. Fulton, Mark G. Davies, Kevin G. Peters, Michael D. Ezekowitz, Per Otto Hagen, Brian H. Annex

Research output: Contribution to journalArticle

Abstract

Vein graft failure is a major limitation of coronary artery and peripheral vascular surgery. Tissue factor (TF), a transmembrane glycoprotein, generates thrombin by initiating the extrinsic coagulation cascade and plays a major role in the response to arterial injury. This study was designed to examine changes in TF protein expression in response to venous bypass grafting. New Zealand White rabbits underwent interposition bypass grafting of the common carotid artery via the ipsilateral external jugular vein. The contralateral control jugular veins (n=6), early vein grafts (1 or 3 days after grafting, n=18), and late vein grafts (14 or 28 days after grafting, n=8)were examined by immunohistochemistry. The presence or absence of TF immunostaining in the intima was assessed in each vessel quadrant. In control veins, intimal TF staining was present in 5 of 24 vessel quadrants. In early vein grafts, TF staining was markedly increased in the intima (72 of 72 quadrants, P<.001 vs control veins), and TF immunostaining colocalized with CD18-positive leukocytes but not with endothelial cells, vascular smooth muscle cells, or RAM11-positive macrophages. In late vein grafts with intimal hyperplasia, TF expression was low or absent in the intima (6 of 32 quadrants, P<.001 vs early vein grafts; P=NS vs control veins), although medial smooth muscle cells expressed TF. Marked changes in TF expression occur in veto grafts. In early vein grafts, TF protein was greatly increased in the intima for at least 3 days and was associated with CD18-positive leukocytes. In late vein grafts with intimal hyperplasia, however, TF protein was not seen in the intima. These findings may have important implications for the development of therapeutic. Strategies to limit vein graft failure.

Original languageEnglish (US)
Pages (from-to)1313-1319
Number of pages7
JournalArteriosclerosis, thrombosis, and vascular biology
Volume17
Issue number7
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Thromboplastin
Veins
Transplants
Proteins
Tunica Intima
Jugular Veins
Smooth Muscle Myocytes
Hyperplasia
Leukocytes
Staining and Labeling
Common Carotid Artery
Vascular Smooth Muscle
Thrombin
Blood Vessels
Coronary Vessels
Glycoproteins
Endothelial Cells
Immunohistochemistry
Macrophages
Rabbits

Keywords

  • Inflammation
  • Intimal hyperplasia
  • Thrombosis
  • Vascular surgery

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Channon, K. M., Fulton, G. J., Davies, M. G., Peters, K. G., Ezekowitz, M. D., Hagen, P. O., & Annex, B. H. (1997). Modulation of tissue factor protein expression in experimental venous bypass grafts. Arteriosclerosis, thrombosis, and vascular biology, 17(7), 1313-1319. https://doi.org/10.1161/01.ATV.17.7.1313

Modulation of tissue factor protein expression in experimental venous bypass grafts. / Channon, Keith M.; Fulton, Gregory J.; Davies, Mark G.; Peters, Kevin G.; Ezekowitz, Michael D.; Hagen, Per Otto; Annex, Brian H.

In: Arteriosclerosis, thrombosis, and vascular biology, Vol. 17, No. 7, 01.01.1997, p. 1313-1319.

Research output: Contribution to journalArticle

Channon, KM, Fulton, GJ, Davies, MG, Peters, KG, Ezekowitz, MD, Hagen, PO & Annex, BH 1997, 'Modulation of tissue factor protein expression in experimental venous bypass grafts', Arteriosclerosis, thrombosis, and vascular biology, vol. 17, no. 7, pp. 1313-1319. https://doi.org/10.1161/01.ATV.17.7.1313
Channon, Keith M. ; Fulton, Gregory J. ; Davies, Mark G. ; Peters, Kevin G. ; Ezekowitz, Michael D. ; Hagen, Per Otto ; Annex, Brian H. / Modulation of tissue factor protein expression in experimental venous bypass grafts. In: Arteriosclerosis, thrombosis, and vascular biology. 1997 ; Vol. 17, No. 7. pp. 1313-1319.
@article{c049959fac064944badeb8f918a8385a,
title = "Modulation of tissue factor protein expression in experimental venous bypass grafts",
abstract = "Vein graft failure is a major limitation of coronary artery and peripheral vascular surgery. Tissue factor (TF), a transmembrane glycoprotein, generates thrombin by initiating the extrinsic coagulation cascade and plays a major role in the response to arterial injury. This study was designed to examine changes in TF protein expression in response to venous bypass grafting. New Zealand White rabbits underwent interposition bypass grafting of the common carotid artery via the ipsilateral external jugular vein. The contralateral control jugular veins (n=6), early vein grafts (1 or 3 days after grafting, n=18), and late vein grafts (14 or 28 days after grafting, n=8)were examined by immunohistochemistry. The presence or absence of TF immunostaining in the intima was assessed in each vessel quadrant. In control veins, intimal TF staining was present in 5 of 24 vessel quadrants. In early vein grafts, TF staining was markedly increased in the intima (72 of 72 quadrants, P<.001 vs control veins), and TF immunostaining colocalized with CD18-positive leukocytes but not with endothelial cells, vascular smooth muscle cells, or RAM11-positive macrophages. In late vein grafts with intimal hyperplasia, TF expression was low or absent in the intima (6 of 32 quadrants, P<.001 vs early vein grafts; P=NS vs control veins), although medial smooth muscle cells expressed TF. Marked changes in TF expression occur in veto grafts. In early vein grafts, TF protein was greatly increased in the intima for at least 3 days and was associated with CD18-positive leukocytes. In late vein grafts with intimal hyperplasia, however, TF protein was not seen in the intima. These findings may have important implications for the development of therapeutic. Strategies to limit vein graft failure.",
keywords = "Inflammation, Intimal hyperplasia, Thrombosis, Vascular surgery",
author = "Channon, {Keith M.} and Fulton, {Gregory J.} and Davies, {Mark G.} and Peters, {Kevin G.} and Ezekowitz, {Michael D.} and Hagen, {Per Otto} and Annex, {Brian H.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1161/01.ATV.17.7.1313",
language = "English (US)",
volume = "17",
pages = "1313--1319",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Modulation of tissue factor protein expression in experimental venous bypass grafts

AU - Channon, Keith M.

AU - Fulton, Gregory J.

AU - Davies, Mark G.

AU - Peters, Kevin G.

AU - Ezekowitz, Michael D.

AU - Hagen, Per Otto

AU - Annex, Brian H.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Vein graft failure is a major limitation of coronary artery and peripheral vascular surgery. Tissue factor (TF), a transmembrane glycoprotein, generates thrombin by initiating the extrinsic coagulation cascade and plays a major role in the response to arterial injury. This study was designed to examine changes in TF protein expression in response to venous bypass grafting. New Zealand White rabbits underwent interposition bypass grafting of the common carotid artery via the ipsilateral external jugular vein. The contralateral control jugular veins (n=6), early vein grafts (1 or 3 days after grafting, n=18), and late vein grafts (14 or 28 days after grafting, n=8)were examined by immunohistochemistry. The presence or absence of TF immunostaining in the intima was assessed in each vessel quadrant. In control veins, intimal TF staining was present in 5 of 24 vessel quadrants. In early vein grafts, TF staining was markedly increased in the intima (72 of 72 quadrants, P<.001 vs control veins), and TF immunostaining colocalized with CD18-positive leukocytes but not with endothelial cells, vascular smooth muscle cells, or RAM11-positive macrophages. In late vein grafts with intimal hyperplasia, TF expression was low or absent in the intima (6 of 32 quadrants, P<.001 vs early vein grafts; P=NS vs control veins), although medial smooth muscle cells expressed TF. Marked changes in TF expression occur in veto grafts. In early vein grafts, TF protein was greatly increased in the intima for at least 3 days and was associated with CD18-positive leukocytes. In late vein grafts with intimal hyperplasia, however, TF protein was not seen in the intima. These findings may have important implications for the development of therapeutic. Strategies to limit vein graft failure.

AB - Vein graft failure is a major limitation of coronary artery and peripheral vascular surgery. Tissue factor (TF), a transmembrane glycoprotein, generates thrombin by initiating the extrinsic coagulation cascade and plays a major role in the response to arterial injury. This study was designed to examine changes in TF protein expression in response to venous bypass grafting. New Zealand White rabbits underwent interposition bypass grafting of the common carotid artery via the ipsilateral external jugular vein. The contralateral control jugular veins (n=6), early vein grafts (1 or 3 days after grafting, n=18), and late vein grafts (14 or 28 days after grafting, n=8)were examined by immunohistochemistry. The presence or absence of TF immunostaining in the intima was assessed in each vessel quadrant. In control veins, intimal TF staining was present in 5 of 24 vessel quadrants. In early vein grafts, TF staining was markedly increased in the intima (72 of 72 quadrants, P<.001 vs control veins), and TF immunostaining colocalized with CD18-positive leukocytes but not with endothelial cells, vascular smooth muscle cells, or RAM11-positive macrophages. In late vein grafts with intimal hyperplasia, TF expression was low or absent in the intima (6 of 32 quadrants, P<.001 vs early vein grafts; P=NS vs control veins), although medial smooth muscle cells expressed TF. Marked changes in TF expression occur in veto grafts. In early vein grafts, TF protein was greatly increased in the intima for at least 3 days and was associated with CD18-positive leukocytes. In late vein grafts with intimal hyperplasia, however, TF protein was not seen in the intima. These findings may have important implications for the development of therapeutic. Strategies to limit vein graft failure.

KW - Inflammation

KW - Intimal hyperplasia

KW - Thrombosis

KW - Vascular surgery

UR - http://www.scopus.com/inward/record.url?scp=0030792963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030792963&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.17.7.1313

DO - 10.1161/01.ATV.17.7.1313

M3 - Article

C2 - 9261261

AN - SCOPUS:0030792963

VL - 17

SP - 1313

EP - 1319

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 7

ER -